Regarding Steady state study in BE studies [Design Issues]

posted by VijithRoy – India, 2020-11-20 05:28 (1243 d 03:52 ago) – Posting: # 22071
Views: 1,290

Hello!

Usually steady state techniques are conducted to maintain constant free drug in plasma with equal elimination. It applies for drugs which come under Time dependent activity.

My question,

1. In what case or particular class of drugs we should go for steady state studies in comparitive BA or BE studies?

2. How does Vidagliptin/metformin (fdc) comes under steady state studies?

Appreciating in advance for your response.

Thank you.


With warm regards,
T. Vijith

Complete thread:

UA Flag
Activity
 Admin contact
22,984 posts in 4,822 threads, 1,651 registered users;
54 visitors (0 registered, 54 guests [including 1 identified bots]).
Forum time: 10:21 CEST (Europe/Vienna)

You can’t fix by analysis
what you bungled by design.    Richard J. Light, Judith D. Singer, John B. Willett

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5